Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities
- Supplementary File 1:
PDF-Document (PDF, 353 KiB)
Ingram, B.; Lumsden, R.S.; Radosavljevic, A.; Kobryn, C. Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities. Pharmaceuticals 2021, 14, 306. https://doi.org/10.3390/ph14040306
Ingram B, Lumsden RS, Radosavljevic A, Kobryn C. Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities. Pharmaceuticals. 2021; 14(4):306. https://doi.org/10.3390/ph14040306
Chicago/Turabian StyleIngram, Beverly, Rebecca S. Lumsden, Adriana Radosavljevic, and Christine Kobryn. 2021. "Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities" Pharmaceuticals 14, no. 4: 306. https://doi.org/10.3390/ph14040306